MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML
Product details
Registration number: SIN17355P
Classification: Prescription Only
Active ingredients: Tirzepatide
Strength: 12.5mg/0.5mL
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: A10BX16
HSA approval date: 10 October 2025
Manufacturer(s):
- BSP Pharmaceuticals SpA
- Resilience US, Inc.
Manufacturing country/countries: UNITED STATES; ITALY
What are the HSA registration number and classification for MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17355P
Classification: Prescription Only
What active ingredients and strength are recorded for MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tirzepatide
Strength: 12.5mg/0.5mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- BSP Pharmaceuticals SpA
- Resilience US, Inc.
Manufacturing country/countries: UNITED STATES; ITALY
Where can I look up MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17355P or the exact product name MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML. The general register link does not preselect this product.
What are the source dates for this MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MOUNJARO SOLUTION FOR INJECTION IN VIAL 12.5MG / 0.5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17355P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)